| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |